Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA

Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis

NCT01163318 ·Status: COMPLETED

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

NCT00234884 ·Status: COMPLETED

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

NCT01502423 ·Status: COMPLETED ·Phase: PHASE2

A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis

NCT01162421 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis

NCT01076205 ·Status: COMPLETED

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

NCT00649545 ·Status: APPROVED_FOR_MARKETING

Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)

NCT01382160 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine

NCT01078610 ·Status: WITHDRAWN

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

NCT01346488 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis

NCT01050998 ·Status: COMPLETED ·Phase: PHASE2

Targeted Ultrasound in Rheumatoid Arthritis

NCT02056184 ·Status: COMPLETED ·Phase: PHASE4

Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

NCT01754727 ·Status: COMPLETED

A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

NCT01078558 ·Status: COMPLETED

A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety

NCT01712178 ·Status: COMPLETED ·Phase: PHASE2

A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

NCT01086033 ·Status: COMPLETED

To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)

NCT02121210 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT00448383 ·Status: COMPLETED ·Phase: PHASE3

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis

NCT00650026 ·Status: APPROVED_FOR_MARKETING

A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT01231321 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Humira in Behcet Patients With Arthritis

NCT01497717 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis

NCT01078571 ·Status: COMPLETED

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

NCT01474876 ·Status: COMPLETED

Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study

NCT02433340 ·Status: COMPLETED ·Phase: PHASE2

Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

NCT02640612 ·Status: COMPLETED ·Phase: PHASE3